Patent 11872244 was granted and assigned to Covidien on January, 2024 by the United States Patent and Trademark Office.
A method of treatment includes agitating a thixotropic oxidized cellulose solution; administering the agitated thixotropic oxidized cellulose solution to a target tissue site; and allowing the agitated thixotropic oxidized cellulose solution to gel at the target tissue site.